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Objective: To compare femorotibial cartilage thickness changes over a 2- vs a 1-year observation period in
knees with radiographic knee osteoarthritis (OA).
Methods: One knee of 346 Osteoarthritis Initiative (OAI) participants was studied at three time points
[baseline (BL), year-1 (Y1), year-2 (Y2) follow-up]: 239 using coronal fast low angle shot (FLASH) and 107
using sagittal double echo at steady state (DESS)MR imaging. Changes in cartilage thicknesswere assessed
in femorotibial cartilage plates and subregions, after manual segmentation with blinding to time-point.
Results: The standardized response mean (SRM) of total joint cartilage thickness over 2 years was
modestly higher than over 1 year (FLASH: 0.44 vs 0.32/0.28 [ﬁrst/second year]; DESS: 0.42 vs
0.39/0.18). For the subregion showing the largest change per knee (OV1), the 2-year SRM was similar
or lower (FLASH: 1.20 vs 1.22/1.61; DESS: 1.38 vs 1.64/1.51) than the 1-year SRM. The changes
in total joint cartilage thickness were not signiﬁcantly different in the ﬁrst and second year (FLASH:
0.8% vs 0.7%; DESS: 1.3% vs 0.8%) and were negatively correlated. Analysis of smallest detectable
changes (SDCs) revealed that only few participants displayed signiﬁcant progression in both consecutive
periods. The location of the subregion contributing to OV1 in each knee was highly inconsistent between
the ﬁrst and second year observation period.
Conclusions: The SRM of region-based cartilage thickness change in OA is modestly larger following
a 2-year vs a 1-year observation period, while it is relatively similar when an OV-approach is chosen.
Structural progression displays strong temporal and spatial heterogeneity at an individual knee level that
should be considered when planning clinical trials.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Magnetic resonance imaging (MRI)ebased cartilage morphom-
etry is increasingly used as a structural endpoint of osteoarthritisWolfgang Wirth, Institute of
ergasse 21, A5020 Salzburg
002-1249.
irth).
s Research Society International. P(OA) progression1e4. This methodology is used in epidemiological
studies and clinical trials, to explore the course of the disease (i.e.,
its natural history), risk factors involved in its onset and progres-
sion (i.e., its etiopathology), and to identify potential effects of
disease modifying interventions. Although OA is a disease that
affects all articular tissues, changes in cartilage thickness have been
shown to be particularly sensitive to change1e9. The Osteoarthritis
Initiative (OAI, http://oai.ucsf.edu/) is an ongoing, publicly and
privately sponsored multi-center study, targeted at identifying
sensitive (imaging) biomarkers of symptomatic knee OA, thatublished by Elsevier Ltd. All rights reserved.
Table I
BL demographics and acquisition intervals for the coronal FLASH (n¼ 239 knees)
and the sagittal DESS sample (n¼ 107 knees)
Demographics at BL
FLASH DESS
(Mean) (SD) (Mean) (SD)
#Knees 239 (238 right, 1 left) 107 (58 right, 49 left)
Women (n¼ 161) (n¼ 63)
Age (years) 63.6 9.4 62.7 8.8
BMI (kg/m^2) 29.3 4.6 29.9 6.3
Men (n¼ 78) (n¼ 44)
Age (years) 63 9.9 63.6 9.4
BMI (kg/m^2) 28.9 4 29.9 6.3
Radiographic readings
(cKLG) (cKLG) (KLG)
(c)KLG 0 0 0 1
(c)KLG 1 12 0 9
(c)KLG 2 113 0 23
(c)KLG 3 113 96 72
(c)KLG 4 1 11 2
BMI¼ Body Mass Index. KLG¼ Kellgren and Lawrence grade obtained from central
readings. cKLG¼Kellgren and Lawrence grades calculated from osteophyte and
joint space narrowing readings at the clinical sites of the OAI (cKLG0: no radio-
graphic signs of OA, cKLG1: doubtful or minute osteophytes if doubtful signiﬁcance,
or isolated mild to moderate joint space narrowing; cKLG2: deﬁnite osteophytes
and unimpaired joint space or isolated severe JSN in combination with no or
questionable osteophytes; cKLG3: Deﬁnite osteophytes and OARSI grade 1e2 joint
space narrowing; cKLG4: deﬁnite osteophytes and OARSI grade 3 joint space
narrowing).
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nology has extended the analysis of cartilage morphology from
total knee cartilage plates to femorotibial subregions10e13, and the
latter has been proposed to be particularly useful when changes are
ranked in each knee according to their magnitude [ordered value
(OV) approach]14,15.
For clinical trials evaluating risk factors of OA progression or
disease modifying interventions, the length of the observation
period (and required sample size) is key in the study design, to be
able to demonstrate the relevant risk factor relationship or treat-
ment effect for a given sample size with statistical conﬁdence.
Whereas the ratio between the real changes occurring and factors
affecting the variability of the measurement (i.e., inter-subject
variability and precision errors) becomes more favorable with
longer observation periods and thus the observed changes more
reliable, longer study periods are associated with higher costs,
higher participant drop-out, and less patent-life for a drug on the
market. If rates of progression in individual knees vary over fairly
short time intervals (e.g., from year-to-year), a longer follow-up
may result in amore homogeneous outcome in terms of rate of loss.
Further, epidemiological and interventional trials commonly rely
on rates of change measured at several follow-up time points.
Whether the observed rate of change during these observation
periods is constant or variable over time, both at a cohort and at an
individual level, has additional implications for the trial design, for
instance when statistical techniques are applied that include intra-
patient variability in the analysis model (e.g., ANCOVA with
repeated measurements). Also, from a perspective of studying risk
factors of OA progression, it is important to explore whether knees
in which high rates of progression are observed during an initial
(longitudinal) observation period (e.g., year-1) are consistent with
knees in which high rates of progression are also observed during
a later follow-up period (e.g., year-2).
One study reported relatively consistent cartilage volume
changes for 2-year and 4.5-year observation periods5. In contrast,
other studies either found the annualized rate of cartilage volume
loss over 24 months to be considerably lower (approximately half)
than that over 6 months6e8, or the annualized cartilage thickness
loss over 24 months to be higher than that over 6 and 12 months,
respectively9. The ﬁndings of these studies were thus inconsistent,
as to whether annualized rates of change for longer study periods
are generally equal, smaller, or larger than those from shorter
periods, but all reported a greater standardized response mean
(SRM) for longer study periods, the SRM being a measure of the
sensitivity to change. Whereas the above studies compared several
follow-up time points with baseline (BL), they did not examine the
consistency of the observed rates of change over two subsequent
observation periods, either at a cohort or an individual knee level.
Also, no prior study has investigated the behaviour of OVs14,15 over
1-year and 2-year observation periods, respectively.
Therefore, the primary objective of this study was to compare
the SRM for changes in cartilage plates, subregions and OVs in
a given cohort for a 2-year vs a 1-year study period. Secondary
objectives were to explore (1) how observed annualized rates of
change (in femorotibial cartilage plates, subregions, and OVs) in the
ﬁrst year relate to those in the second year and to those over 2
years, and (2) how consistent the individual changes are over the
two 1-year periods, i.e., are ﬁrst year progressors corresponding
with second year progressors, and are the subregions with the
greatest observed rate of change (OV 1) during the ﬁrst year
consistent with those during the second year?
Pleasenote that the “ﬁrst ” and “second”yearobservationperiods
were deﬁned by the study and not by individual disease state, since
the beginning of disease is challenging to deﬁne inOA, and since this
reﬂects the way inwhich participants are recruited in clinical trials.Methods
MRI sequences and participants
In the OAI, 4796 participants are studied at annual time intervals
over a period of 4 years16 using ﬁxed ﬂexion radiographs17,18 and
MRI16. The OAI involves MRI acquisitions of a coronal fast low angle
shot (FLASH) sequence in the right knee13,19e22 and sagittal double
echo at steady state (DESS) images in both knees23,24. A recent
study reported similar rates of change between FLASH and DESS in
the same knees25. The current study was funded by a consortium of
the OAI Coordinating Center and several companies (see acknowl-
edgements) and relied on two samples, one based on coronal
FLASH and one on sagittal DESS. The OAI inclusion and exclusion
criteria and imaging protocol have been described
previously13,20,22,26.
The FLASH sample consisted of 239 knees from 239 participants
of the progression subcohort (see Table I), who were selected for
comparing the rate of change between DESS and FLASH in a cohort
with unilateral medial JSN19,25, or were chosen by ascending OAI ID
from the ﬁrst half of the OAI cohort (public-use data sets 0.C.1 and
1.C.1), based on calculated KellgreneLawrence (cKLG) grades from
the clinical site screening readings. The ascending order of OAI IDs
was chosen to comprise a “random” sample; only the ﬁrst half of
the total cohort was used, because the 2-year imaging data of the
second half of the cohort were not yet public when the participants
were selected for segmentation. The inclusion criterion for the
knees selected from the ﬁrst half of the OAI cohort was presence of
cKLG2 or 3 in the study knee (Table I), independent of symptom
status or other factors.
The DESS sample has been previously released for public-use
(http://www.oai.ucsf.edu/datarelease/SASDocs/kMRI_QCart_Eckstein_
descrip.pdf) and consisted of 107 kneeswith frequent pain (deﬁned as:
pain onmost days of amonth inpast 12months); itwas selected by the
OAI coordinating center as part of a “core image assessment sample” of
theprogressionsubcohort (Table I). CentralKLGreadingswereavailable
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site cKLG readings (Table I).
Image analysis
After initial quality control (MH), segmentation of the weight-
bearing femorotibial cartilage plates was performed in the FLASH
and DESS images by seven experienced operators, with blinding to
the time-point of acquisition and to the BL radiographic readings.
One randomly selected time-point was used as the “reference” data
set and was displayed for comparison during the segmentation of
the other time points. Segmentation of the subchondral bone area
(tAB) and the area of the cartilage surface (AC) were completed in
the medial (MT) and lateral tibia (LT), and in the weight-bearing
part of the medial (cMF) and the lateral (cLF) femoral condyle27. A
60% distance criterion between the trochlear notch and the
posterior ends of the femoral condyles was applied to deﬁne the
weight-bearing portion of the condyles in both the coronal and
sagittal MR images27,28 (Fig. 1). All segmentations underwent
quality control by an expert (S.M.) and were corrected by the
operators, if necessary. The mean cartilage thickness over the tAB
(ThCtAB) was computed in femorotibial cartilage plates (MT, LT,
cMF, and cLF), the medial and lateral femorotibial compartment
(MFTC¼MTþcMF; LFTC¼ LTþcLF), the total femorotibial joint
(FTJ¼MFTCþ LFTC), and in 16 femorotibial subregions [ﬁve in MT
and LT, three in cMFand cLF, respectively; Fig.1 (c, d)]12. The current
analysis regarded the coronal FLASH and sagittal DESS samples
separately, and it relied on segmentation of every second slice ofFig. 1. Image acquisition protocols and anatomical subregions analyzed: (a) Coronal FLASH
from superior: (MT¼medial tibia, LT¼ lateral tibia; c¼ central, e¼ external, i¼ internal, a¼
cMF¼weight-bearing (central) medial femoral cartilage, cLF¼weight-bearing (central) latthe sagittal DESS (every 1.4 mm), as this has been shown to provide
a similar sensitivity to change as the analysis of every 0.7 mm
slice25.
Statistical analysis
The mean change (MC), the 95% conﬁdence interval of the
change (CI: lower/upper limit), and the standard deviation of the
observed change (SD) in ThCtAB (mm)were determined between BL
and year-1 follow-up (Y1), between Y1 and year-2 follow-up (Y2),
and between BL and Y2. Percent changes were obtained by relating
the MC to the mean ThCtAB of the reference time-point and the
SRM was computed by relating the MC to the SD. All observed
changeswere normalized to a 365-day-period: The average SD BL
to Y1 period was 389 38 days, and the Y1 to Y2 period was
353 46 days.
Statistical signiﬁcance of the differences between the changes
observed in year-1 vs year-2 was tested using the Wilcoxon signed
rank test. To facilitate the comparison between the three intervals,
we calculated the relationship (factor) between the observed
averaged second and ﬁrst-year changes [(Y2Y1)/(Y1BL)] and
between the observed averaged 2-year and ﬁrst year changes
[(Y2BL)/(Y1BL)]. The correlation of the observed changes (ﬁrst
year vs second year, and ﬁrst year vs 2-year) was determined using
both parametric (Pearson r) and non-parametric (Spearman rho)
coefﬁcients.
The recently proposed OVs approach14 was applied to observed
longitudinal changes in ThCtAB in all 16 (medial and lateral)with water excitation (b) Sagittal DESS with water excitation (c) Tibial cartilage viewed
anterior, and p¼ posterior) (d) Weight-bearing femoral cartilage viewed from inferior:
eral femoral cartilage; c¼ central, e¼ external, i¼ internal,
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BL and follow-up were sorted in each knee in ascending order, i.e.,
the subregional value with the largest observed thickness decrease
being assigned to OV1, the value with the second-largest observed
decrease to OV2, and so forth12. The value of the subregionwith the
smallest observed thickness decrease (or largest increase) was
assigned to OV16. Separate sets of OV variables were computed for
the ﬁrst and second year, and for the 2-year-period.
The smallest detectable change (SDC) method29 was used to
identify knees with signiﬁcant loss of ThCtAB (progression). Test-
retest precision errors for repeated measurements were used for
this purpose, as derived from paired analysis of FLASH and DESS
images in the OAI pilot study30.
Results
The SRM for the FTJ in the FLASH/DESS sample was0.44/0.42
over the 2-year observation period and was higher than that in
the ﬁrst year (0.32/0.39) and second year (0.28/0.18)
(Tables II & III). In the FLASH cohort, the 2-year SRM of MT was
twice that over the ﬁrst year, but in cLF it was only 1.1 times thatTable II
Coronal FLASH sample (n¼ 239): Mean observed longitudinal change (MC in mm) and sen
time periods (BL to Y1, Y1 to Y2) and for the entire observation period (BL to Y2 follow-
BL/ Y1 Y1/ Y2
MC CI MC % SRM MC CI MC %
FTJ 59 (83/36) 0.8 0.32 49 (71/26) 0.7
MFTC 31 (47/15) 0.9 0.24 27 (40/14) 0.8
LFTC 28 (42/15) 0.7 0.27 22 (36/7) 0.6
MT 9 (16/2) 0.5 0.16 11 (18/4) 0.7
cMF 23 (34/11) 1.3 0.26 15 (24/6) 0.9
LT 17 (25/10) 0.9 0.30 16 (24/8) 0.8
cLF 11 (20/2) 0.6 0.16 5 (16/5) 0.3
cMT 16 (28/4) 0.7 0.16 22 (35/10) 0.9
eMT 17 (29/6) 1.2 0.19 27 (38/16) 1.9
iMT 7 (15/1) 0.4 0.11 4 (6/14) 0.2
aMT 2 (11/8) 0.1 0.03 1 (10/9) 0.1
pMT 5 (13/2) 0.4 0.09 14 (22/5) 0.9
ccMF 34 (51/18) 1.6 0.27 21 (36/7) 1.0
ecMF 16 (28/4) 1.1 0.17 13 (23/2) 0.9
icMF 19 (30/8) 1.0 0.23 13 (23/3) 0.7
cLT 34 (48/20) 1.1 0.32 26 (42/10) 0.9
eLT 11 (20/1) 0.7 0.14 13 (22/3) 0.8
iLT 28 (39/16) 1.5 0.31 14 (24/3) 0.8
aLT 4 (12/4) 0.2 0.07 15 (26/3) 0.9
pLT 11 (24/2) 0.6 0.11 14 (27/1) 0.8
ccLF 16 (30/3) 0.7 0.16 9 (24/7) 0.4
ecLF 9 (19/2) 0.6 0.11 0 (12/12) 0.0
icLF 10 (19/0) 0.6 0.13 9 (20/3) 0.5
OV 1 150 (166/135) 7.5 1.22 169 (182/156) 8.7
OV 2 112 (125/99) 6.2 1.10 116 (126/106) 6.4
OV 3 82 (92/72) 4.5 1.05 87 (95/79) 4.8
OV 4 64 (72/55) 3.6 0.95 66 (73/60) 3.8
OV 5 50 (58/42) 2.6 0.81 52 (59/46) 3.0
OV 6 37 (44/30) 2.1 0.69 39 (44/33) 2.2
OV 7 26 (31/21) 1.4 0.65 27 (32/22) 1.6
OV 8 15 (20/10) 0.9 0.40 17 (22/12) 1.0
OV 9 6 (10/1) 0.3 0.16 5 (10/0) 0.3
OV 10 3 (1/8) 0.2 0.09 6 (1/12) 0.4
OV 11 13 (9/18) 0.8 0.37 19 (14/24) 1.1
OV 12 25 (20/30) 1.4 0.69 31 (25/36) 1.7
OV 13 37 (32/41) 2.1 1.05 46 (40/51) 2.6
OV 14 51 (47/56) 2.9 1.40 63 (56/69) 3.5
OV 15 70 (64/75) 3.8 1.68 85 (78/92) 4.7
OV 16 102 (95/109) 5.5 1.87 126 (117/135) 6.6
CI: 95% upper/lower limit in mm;MC%¼mean change in %; SRM¼mean change/standard
with the ﬁrst year (BL/ Y1); F2¼ factor for changes over a 2-year-period (BL/ Y2) com
medial/lateral femoral condyle; femorotibial subregions: (c¼ central, e¼ external, i¼ in
thickness.
* MC.
y SRM.over the ﬁrst year. In the DESS sample, the medial cartilage plates
(MT, cMF) displayed an approximately 25% greater SRM over 2
years than in the ﬁrst year, but the SRM was similar between the
2-year-period and the ﬁrst year for the lateral plates (LT, cLF). For
OV1, the 2-year SRM (1.20) was similar to the ﬁrst-year SRM
(1.22) for FLASH (Table II) andwas lower over 2 years (1.38) than
in the ﬁrst year (1.64) with the DESS (Table III).
The observed rate of change across the entire (FTJ) joint was
1.5%/2.0% for FLASH/DESS over the 2-year-period, 0.8%/1.3%
in the ﬁrst year, and0.7%/0.8% in the second year (Tables II & III).
For the entire FTJ, the changes observed over 2-year were 83%
higher than the ﬁrst year changes in the FLASH sample, and they
were 60% higher than the ﬁrst year changes in the DESS sample;
The rates of change in cartilage plates and subregions were not
signiﬁcantly different between the ﬁrst and the second year (Table
II & III).
The rates of change measured for OVs were also similar in the
ﬁrst and second year, except for some of the extreme OVs, specif-
ically OV1 (P¼ 0.004), OV14 (P¼ 0.013), OV15 (P¼ 0.002) and OV16
(P< 0.001) with the FLASH, and OV16 (P¼ 0.015) with the DESS.
OV1 decreased by150 mm (95% CI:166 mm/135 mm) in the ﬁrstsitivity to change SRM in cartilage thickness (ThCtAB) assessed for two consecutive
up)
BL/ Y2
SRM F1* F1y MC CI MC % SRM F2* F2y
0.28 0.8 0.9 108 (139/76) 1.5 0.44 1.8 1.4
0.27 0.9 1.1 58 (78/38) 1.6 0.37 1.9 1.5
0.19 0.8 0.7 50 (70/30) 1.3 0.32 1.8 1.2
0.21 1.3 1.3 20 (29/12) 1.2 0.32 2.3 2.0
0.21 0.7 0.8 38 (52/24) 2.1 0.34 1.7 1.3
0.26 0.9 0.9 33 (44/23) 1.7 0.41 1.9 1.4
0.07 0.5 0.4 17 (29/4) 0.9 0.17 1.5 1.1
0.22 1.4 1.4 38 (53/23) 1.6 0.32 2.4 2.0
0.31 1.5 1.6 44 (59/30) 3.1 0.38 2.6 2.0
0.05 0.6 0.5 3 (11/6) 0.2 0.04 0.4 0.4
0.01 0.4 0.4 3 (13/8) 0.2 0.03 1.4 1.3
0.21 2.5 2.4 19 (28/10) 1.3 0.28 3.5 3.1
0.19 0.6 0.7 56 (77/35) 2.6 0.33 1.6 1.2
0.15 0.8 0.9 28 (44/13) 2.0 0.24 1.8 1.4
0.16 0.7 0.7 32 (44/20) 1.7 0.33 1.7 1.5
0.21 0.8 0.7 60 (79/42) 2.0 0.41 1.8 1.3
0.17 1.2 1.2 24 (36/11) 1.5 0.23 2.2 1.7
0.16 0.5 0.5 41 (54/29) 2.3 0.42 1.5 1.4
0.17 3.6 2.4 19 (31/7) 1.1 0.20 4.5 2.9
0.13 1.3 1.2 25 (40/9) 1.4 0.21 2.2 1.9
0.07 0.5 0.5 26 (44/7) 1.1 0.18 1.6 1.1
0.00 0.0 0.0 8 (23/7) 0.5 0.07 0.9 0.6
0.09 0.9 0.7 18 (29/7) 1.0 0.21 1.9 1.5
1.61 1.1 1.3 202 (223/180) 10.0 1.20 1.3 1.0
1.49 1.0 1.3 147 (164/131) 8.2 1.14 1.3 1.0
1.39 1.1 1.3 110 (124/97) 6.1 1.02 1.4 1.0
1.24 1.0 1.3 87 (100/75) 4.9 0.92 1.4 1.0
1.09 1.1 1.3 67 (77/57) 3.7 0.86 1.4 1.1
0.87 1.0 1.3 53 (61/44) 3.0 0.77 1.4 1.1
0.66 1.1 1.0 38 (45/31) 2.1 0.67 1.5 1.0
0.42 1.1 1.0 27 (34/20) 1.6 0.51 1.8 1.3
0.13 0.9 0.8 15 (21/8) 0.8 0.30 2.7 1.9
0.16 2.0 1.7 4 (10/2) 0.2 0.08 1.1 0.9
0.46 1.4 1.3 8 (2/14) 0.5 0.18 0.6 0.5
0.73 1.2 1.1 21 (16/27) 1.2 0.52 0.9 0.8
1.02 1.2 1.0 35 (30/41) 2.0 0.81 1.0 0.8
1.28 1.2 0.9 54 (48/60) 3.1 1.21 1.1 0.9
1.56 1.2 0.9 75 (69/81) 4.3 1.56 1.1 0.9
1.78 1.2 1.0 114 (105/123) 6.0 1.63 1.1 0.9
deviation of change. F1¼ factor for changes in the second year (Y1/ Y2) compared
pared with the ﬁrst year (BL/ Y1); cMF/cLF¼weight-bearing (central) part of the
ternal, a¼ anterior, and p¼ posterior); OV¼ ordered values of change in cartilage
Table III
Sagittal DESS sample: Mean observed longitudinal change (MC in mm) and sensitivity to change SRM in cartilage thickness (ThCtAB, n¼ 107 knees) assessed for two
consecutive time periods (BL to Y1, Y1 to Y2) and for the entire observation period (BL to Y2 follow-up).
BL/ Y1 Y1/ Y2 BL/ Y2
MC CI MC % SRM MC CI MC % SRM F1* F1y MC CI MC % SRM F2* F2y
FTJ 87 (130/44) 1.3 0.39 51 (105/2) 0.8 0.18 0.6 0.5 139 (202/76) 2.0 0.42 1.6 1.1
MFTC 50 (80/20) 1.5 0.32 36 (71/2) 1.1 0.20 0.7 0.6 86 (128/44) 2.6 0.39 1.7 1.2
LFTC 37 (59/15) 1.1 0.32 15 (44/14) 0.4 0.10 0.4 0.3 52 (85/19) 1.5 0.30 1.4 0.9
MT 20 (35/4) 1.2 0.24 12 (29/5) 0.7 0.13 0.6 0.5 32 (51/13) 1.9 0.32 1.6 1.3
cMF 30 (49/11) 1.8 0.30 24 (47/1) 1.5 0.20 0.8 0.7 54 (82/27) 3.2 0.38 1.8 1.2
LT 25 (38/12) 1.4 0.36 11 (26/5) 0.6 0.13 0.4 0.4 36 (54/18) 2.0 0.38 1.4 1.0
cLF 12 (26/3) 0.7 0.16 4 (24/16) 0.2 0.04 0.3 0.3 16 (37/4) 0.9 0.15 1.4 1.0
cMT 64 (94/34) 2.9 0.41 41 (70/12) 1.9 0.27 0.6 0.7 105 (143/67) 4.8 0.53 1.6 1.3
eMT 48 (77/19) 3.7 0.31 32 (58/6) 2.6 0.24 0.7 0.8 81 (118/44) 6.2 0.42 1.7 1.3
iMT 19 (9/46) 0.9 0.13 8 (25/41) 0.4 0.05 0.4 0.4 27 (5/58) 1.3 0.16 1.4 1.2
aMT 4 (20/12) 0.3 0.05 10 (32/12) 0.7 0.09 2.6 1.9 15 (34/5) 1.0 0.14 3.7 3.0
pMT 2 (15/11) 0.2 0.03 10 (7/27) 0.7 0.11 4.5 3.4 8 (8/24) 0.5 0.09 3.5 2.8
ccMF 47 (75/18) 2.5 0.31 34 (66/3) 1.9 0.21 0.7 0.7 81 (117/44) 4.3 0.43 1.7 1.4
ecMF 33 (56/10) 2.5 0.28 26 (52/1) 2.0 0.18 0.8 0.7 58 (93/23) 4.4 0.32 1.8 1.1
icMF 13 (33/8) 0.7 0.12 12 (36/12) 0.6 0.10 0.9 0.8 25 (49/0) 1.3 0.19 1.9 1.6
cLT 50 (74/26) 2.0 0.40 25 (55/6) 1.0 0.16 0.5 0.4 75 (107/42) 3.0 0.44 1.5 1.1
eLT 14 (32/3) 1.0 0.16 15 (34/4) 1.1 0.16 1.1 1.0 29 (48/10) 2.0 0.29 2.0 1.8
iLT 29 (50/9) 1.7 0.28 30 (59/0) 1.7 0.19 1.0 0.7 58 (87/30) 3.4 0.39 2.0 1.4
aLT 9 (24/7) 0.6 0.11 8 (11/27) 0.5 0.08 0.9 0.7 1 (21/18) 0.1 0.01 0.2 0.1
pLT 27 (45/8) 1.8 0.28 1 (17/14) 0.1 0.02 0.1 0.1 27 (51/3) 1.8 0.22 1.0 0.8
ccLF 29 (51/7) 1.4 0.25 12 (15/40) 0.6 0.09 0.4 0.3 17 (46/13) 0.8 0.11 0.6 0.4
ecLF 11 (34/11) 0.7 0.09 14 (41/12) 0.9 0.10 1.3 1.1 25 (53/3) 1.6 0.17 2.3 1.8
icLF 2 (21/17) 0.1 0.02 3 (29/23) 0.2 0.02 1.4 1.0 5 (32/22) 0.3 0.04 2.6 1.8
OV 1 221 (247/196) 12.3 1.64 228 (257/199) 12.9 1.51 1.0 0.9 275 (314/237) 15.2 1.38 1.2 0.8
OV 2 154 (174/134) 9.2 1.48 157 (179/135) 9.4 1.38 1.0 0.9 203 (235/172) 12.2 1.23 1.3 0.8
OV 3 117 (131/102) 6.9 1.54 119 (138/100) 7.0 1.19 1.0 0.8 156 (181/131) 9.2 1.19 1.3 0.8
OV 4 89 (101/76) 5.2 1.36 90 (106/73) 5.4 1.03 1.0 0.8 121 (141/102) 7.3 1.18 1.4 0.9
OV 5 70 (82/59) 4.1 1.14 68 (83/53) 4.1 0.87 1.0 0.8 92 (110/74) 5.5 1.00 1.3 0.9
OV 6 56 (67/44) 3.3 0.93 48 (61/34) 2.8 0.68 0.9 0.7 74 (90/58) 4.3 0.87 1.3 0.9
OV 7 41 (52/30) 2.5 0.71 33 (45/20) 2.1 0.49 0.8 0.7 54 (69/39) 3.2 0.70 1.3 1.0
OV 8 27 (37/16) 1.6 0.49 17 (29/4) 1.2 0.26 0.6 0.5 35 (49/20) 2.2 0.47 1.3 0.9
OV 9 12 (22/1) 0.7 0.22 0 (13/13) 0.0 0.00 0.0 0.0 19 (32/5) 1.0 0.26 1.6 1.2
OV 10 2 (8/12) 0.2 0.04 17 (4/29) 0.9 0.26 7.6 6.3 3 (16/10) 0.1 0.04 1.2 1.0
OV 11 18 (8/29) 1.1 0.35 29 (17/42) 1.7 0.46 1.6 1.3 14 (1/28) 0.9 0.21 0.8 0.6
OV 12 36 (26/46) 2.1 0.68 49 (36/61) 3.0 0.74 1.4 1.1 34 (21/48) 2.0 0.49 1.0 0.7
OV 13 51 (40/61) 3.0 0.93 68 (55/80) 4.1 1.00 1.3 1.1 55 (42/69) 3.2 0.78 1.1 0.8
OV 14 70 (59/81) 4.3 1.24 88 (75/101) 5.2 1.28 1.3 1.0 78 (63/92) 4.5 1.02 1.1 0.8
OV 15 97 (85/108) 5.7 1.61 120 (105/135) 6.8 1.53 1.2 1.0 115 (99/131) 6.5 1.38 1.2 0.9
OV 16 152 (134/169) 8.6 1.66 186 (164/207) 10.6 1.67 1.2 1.0 170 (151/190) 9.8 1.67 1.1 1.0
CI: 95% upper/lower limit in mm;MC %¼mean change in %; SRM¼mean change/standard deviation of change. F1¼ factor for changes in the second year (Y1/ Y2) compared
with the ﬁrst year (BL/ Y1); F2¼ factor for changes over a 2-year-period (BL/ Y2) compared with the ﬁrst year (BL/ Y1); cMF/cLF¼weight-bearing (central) part of the
medial/lateral femoral condyle; femorotibial subregions: (c¼ central, e¼ external, i¼ internal, a¼ anterior, and p¼ posterior); OV¼ ordered values of change in cartilage
thickness. JSW¼ joint space width.
* MC.
y SRM.
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with the FLASH, while a loss of 221 mm (95% CI: 247 mm/
196 mm) was noted in the ﬁrst and a loss of 228 mm (95% CI:
257 mm/199 mm) in the second year with the DESS [Tables II & III,
Fig. 2(c)]. The observed 2-year change in OV1 was higher than that
over 1-year, the factor being 1.3 for FLASH and 1.2 for DESS (Tables II
& III).
Although the changes observed during the ﬁrst year were
moderately to strongly positively correlated with the changes
during the full 2-year-period. (Table IV), the changes observed
during the second year were negatively correlatedwith those in the
ﬁrst year, except for the ﬁrst OVs (Table IV). This ﬁnding was
consistent between the FLASH and the DESS cohort [Fig. 3 (a, b)].
In the FLASH cohort, 19% FTJ progressors were observed (SDC
analysis) in the ﬁrst and 24% in the second year (Table V), and with
the DESS there were 31% (ﬁrst year) vs only 18% progressors
(second year), respectively. Only 4% of the FLASH and 7% of the
DESS cases, however, showed progression above the respective
threshold during both periods (Table V).
OV1 rarely originated from the same subregion in the ﬁrst and
second year (FLASH: 3.3%; DESS: 2.8%). OV1 came from a differentsubregion but from the same cartilage plate in about 20% of the
cases (both FLASH and DESS), it came from a different subregion of
the same compartment but not the same plate in 27% (FLASH) to
31% (DESS) of the cases, and it even came from a subregion of the
opposite femorotibial compartment in almost half of the cases
(FLASH: 50%, DESS: 47%). The subregion assigned to OV1 over the
2-year-period, however, was usually identical to either the one
representing OV1 in ﬁrst or in the second year, respectively (FLASH:
62%, DESS: 64%).
Discussion
The primary objective of this study was to compare the SRM for
changes in cartilage plates, subregions and OVs in a given cohort
following a 2-year vs a 1-year study period; secondary objectives
were to explore how the observed annualized rate of change in the
ﬁrst year relates to that in the second year (and to that over 2 years),
and how consistent the observed individual changes are over the
two 1-year periods. Key results were that the SRM for region-based
parameters over 2 years was modestly larger than that obtained
during the ﬁrst year, while the 2-year SRMs for OVs were similar or
Fig. 2. Longitudinal change in cartilage thickness (in mm) between BL and Y1 and between Y1 and Y2. (a) and (c) Coronal FLASH sample (n¼ 239); (b) and (d) Sagittal DESS sample
(n¼ 107) sample Graphs (a) and (b) show the change in the MT (dark continuous line) and in the LT (light continuous line), as well as in the weight-bearing (central) part of the
medial femoral condyle (dark dashed line) and in the lateral femoral condyle (light dashed line) Graphs (c) and (d) show the change in the 16 OVs (OV1eOV16), from bottom to top.
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parameters were negatively correlated and did not differ statisti-
cally signiﬁcant between the ﬁrst and the second year. The location
of the subregion with the greatest observed rate of change (OV1)
was found to be highly inconsistent between the ﬁrst and the
second year.
A limitation of the study is that cartilage segmentation of the
intermediate (1-year) time-point was used in the calculation of the
rate of change in both 1-year observation periods. The reported
negative correlation between the ﬁrst and second year changes may
thus partly originate from the precision errors occurring when
measuring this time-point30e33, e.g., overestimating the cartilage
thickness at1year follow-upcauses too small changesduring theﬁrst
and too large changesduring the secondyear inknees showing lossof
cartilage thickness, whereas underestimating the cartilage thickness
at 1 year follow-up causes too large changes during the ﬁrst and too
small changes during the second year in knees showing negativechanges. The non-linearity of the rate of change, however, was also
conﬁrmed by the results from the SDC analysis, which accounts for
the precision errors of the measurement methodology. Another
limitation of the study is the difference in the length of the ﬁrst and
the second year of the observation period, aswell as the variability of
the observation periods between participants. To allow for a quanti-
tative comparisonofboth time intervals, all changeswerenormalized
to the respective length of the observation periods in each of the
participants. A strength of the study is the inclusion of two separate
cohorts that were imaged with different MR sequences, involving
both different image orientations and contrasts. The inclusion of
different image orientations was particularly relevant in context of
the subregional and OV analysis, because the largest partial volume
effects for the coronal (FLASH) images occur at different locations
than for the sagittal (DESS) images.
As reported in previous studies5e9, the SRM was higher over a 2
year than over 1 year observation period for region-based
Table IV
Correlation of observed longitudinal changes in cartilage thickness (ThCtAB)
assessed for two consecutive time periods (BL to Y1, and BL to Y2) sharing the same
intermediate time-point; r¼ Pearson and r¼ non-parametric Spearman correlation
coefﬁcient
Coronal FLASHSample (n¼ 239) Sagittal DESS Sample (n¼ 107)
BL/ Y1 vs
Y1/ Y2
BL/ Y1 vs
BL/ Y2
BL/ Y1 vs
Y1/ Y2
BL/ Y1 vs
BL/ Y2
r r r r r r r r
FTJ .06 .19 .71 .52 .16 .25 .54 .56
MFTC .08 .26 .77 .50 .15 .31 .58 .52
LFTC .02 .26 .66 .49 .20 .22 .49 .49
MT .32 .42 .58 .40 .32 .38 .53 .47
cMF .05 .20 .76 .52 .15 .28 .57 .49
LT .09 .21 .66 .56 .22 .26 .53 .54
cLF .18 .37 .56 .40 .30 .30 .42 .43
cMT .29 .41 .59 .38 .17 .27 .67 .53
eMT .14 .34 .67 .42 .10 .26 .72 .59
iMT .57 .53 .28 .28 .48 .45 .39 .39
aMT .38 .46 .56 .41 .47 .48 .27 .34
pMT .41 .39 .50 .49 .45 .41 .33 .33
ccMF .06 .24 .73 .50 .26 .32 .56 .45
ecMF .08 .25 .72 .48 .00 .17 .65 .53
icMF .31 .37 .60 .46 .39 .41 .46 .52
cLT .20 .24 .58 .47 .30 .38 .44 .45
eLT .09 .18 .68 .52 .44 .43 .47 .47
iLT .36 .39 .61 .49 .39 .42 .33 .41
aLT .24 .32 .42 .41 .36 .32 .45 .45
pLT .31 .35 .57 .53 .03 .11 .75 .64
ccLF .20 .40 .56 .33 .30 .43 .47 .34
ecLF .09 .34 .63 .49 .33 .28 .48 .45
icLF .43 .41 .38 .37 .32 .30 .40 .39
OV 1 .13 .11 .69 .43 .13 .06 .64 .46
OV 2 .16 .02 .72 .43 .16 .03 .69 .56
OV 3 .08 .03 .74 .38 .05 .07 .56 .56
OV 4 .02 .11 .74 .42 .09 .19 .44 .50
OV 5 .01 .11 .73 .48 .12 .24 .51 .50
OV 6 .05 .17 .66 .45 .15 .26 .55 .51
OV 7 .17 .24 .53 .42 .16 .25 .46 .51
OV 8 .20 .23 .50 .41 .19 .25 .46 .50
OV 9 .25 .30 .51 .39 .24 .32 .41 .44
OV 10 .22 .28 .53 .40 .30 .35 .36 .38
OV 11 .23 .27 .51 .41 .27 .29 .42 .41
OV 12 .23 .24 .46 .41 .17 .21 .49 .46
OV 13 .19 .20 .45 .43 .17 .19 .49 .46
OV 14 .14 .18 .45 .42 .19 .20 .42 .38
OV 15 .11 .13 .41 .39 .16 .20 .39 .36
OV 16 .03 .01 .44 .40 .03 .03 .28 .34
Bold correlation coefﬁcients were signiﬁcant at (P< 0.01). cMF/cLF¼weight-
bearing (central) part of the medial/lateral femoral condyle; Femorotibial subre-
gions: (c¼ central, e¼ external, i¼ internal, a¼ anterior, and p¼ posterior);
OV¼ ordered values of change in cartilage thickness.
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measurement error becomes more favorable with longer observa-
tion periods and may result in a greater homogeneity in rates of
cartilage loss over longer follow-up intervals. Except for the MT of
the FLASH sample, however, the SRMwas less than twice (and often
<1.5) over 2 years when compared with the ﬁrst year period. For
OV1, the SRM observed over 2 years in the DESS sample was even
lower than that in the ﬁrst (or second) year. This is most likely
explained by the relatively large inconsistency between subregions
representing OV1 in the ﬁrst and second year at an individual level
(see below), and by the fact that this inconsistency increases the SD
(of observed change) more strongly than the actual signal.
The observed annualized cartilage thickness changes in cartilage
regions were not signiﬁcantly different between the second and the
ﬁrst year of the 2-year observation period, although a trend
towards lower values in the second year was apparent. This trend
was not observed for the rate of change of OV1, whichwas similar inboth 1-year periods in the DESS sample andwhichwas signiﬁcantly
higher in the second than in the ﬁrst year in the FLASH sample. The
rate of change in OV16, the region showing the smallest loss or e
more often e the region showing the largest increase in cartilage
thickness, was signiﬁcantly greater during the second than during
the ﬁrst year. This signiﬁcant increase in cartilage thickness may
reﬂect subregional cartilage swelling or hypertrophy34 and may
have contributed to the trend of the regional and subregional
decrease in the rate of change in the second year. This may further
indicate that OA disease activity can change over relatively short
time periods, and that MRI-measurements may reﬂect these
changes; however, this observation has to be conﬁrmed in larger
cohorts and over longer observation periods.
The rates of change observed for OV1 generally originated from
different subregions, often even from the opposite femorotibial
compartment. A possible explanation for this spatial inconsistency
is that the subregional changes are susceptible to a regression to the
mean effect35,36, i.e., subregions that showed an extreme change in
the ﬁrst measurement are likely to show a change closer to the
center of the distribution of the changes during the second period
due to both precision error and natural variation of change. It is
difﬁcult to estimate the potential contribution of these two factors
to the observed inconsistency: Likely, precision errors play a rela-
tively important role in knees with a low overall rate of change,
whereas the natural variation makes a relevant contribution in
knees with greater changes (i.e., the progressors). One may expect
that the spatial inconsistency of OV1 (between compartments) is
less in knees with relatively strong malalignment, given that
regional (and subregional) rates of change have been shown to be
highly dependent on varus- and valgus-alignment, respectively37.
However, alignment measurements are not yet available from the
OAI for the sample studied here.
For regions and subregions, negative correlations were found
between the observed rates of change in the second vs the ﬁrst year;
this was conﬁrmed by results from the SDC analysis, showing that
“progressors” during the ﬁrst year were not necessarily the same as
those during the second year. The fact that, at a cohort level, the
second year changes in region-based parameters were not signiﬁ-
cantly different from those in the ﬁrst year highlights that the
longitudinal inconsistency of the rate of change in individual knees
doesnot translate to the cohort level, if the cohort is sufﬁciently large.
However, the progression observed in a kneeduring a relatively short
observation period cannot be reliably projected into the near future.
This may be caused by different levels of disease activity during
different time periods throughout the study or possibly because of
altered loading patterns as a reaction to knee pain. In contrast to the
ﬁndings fromthe current study,Wluka et al5 reportednoevidence for
a non-linearity of the annualized rate of change in individual knee
cartilage volumes over 2 and 4.5 year periods, respectively. Given its
relevance for studies investigating BL risk factors and disease
progression, this discrepancy needs to be further investigated e.g., in
studies with longer observation periods, in which the relationship
between precision errors and true changes is more favorable.
In conclusion, this study ﬁnds that the SRM for the observed
change in region-based cartilage thickness measurements was
modestly larger for a 2-year vs a 1-year observation period, because
not only the observed rate of change but also the heterogeneity of
change increased for most of the femorotibial cartilage plates and
subregions. When analyzing the subregion displaying the greatest
rate of change in each knee (OV1), the SRMs over 2 years were not
higher than those over 1 year, most likely because of the spatial
heterogeneity of subregions contributing to OV1 in the ﬁrst and
second year, respectively. The observed regional changes observed
in the ﬁrst year were generally negatively correlated with those in
the second year, and progression in the same cartilage plate in two
Fig. 3. Scatterplot of the change in cartilage thickness (in mm) between BL and Y1 and between Y1 and Y2. (a) and (c) Coronal FLASH sample (n¼ 239); (b) and (d) Sagittal
DESS sample (n¼ 107) sample. Graphs (a) und (b) illustrate the change in the MFTC Graphs (c) und (d) illustrate the change in the subregion with the largest changes in each
participants (OV 1).
Table V
Number of knees showing a change in cartilage thickness (ThCtAB) that is greater
than the threshold (in mm) required to deﬁne a “progressor” by the methodology of
the SDC in the ﬁrst, in the second year, and over both years, respectively. The results
are given for the FLASH (n¼ 239 knees) and the DESS cohort (n¼ 107 knees).
Threshold Year-1 Year-2 Bothyears
mm N % N % N %
FLASH (n¼ 239) FTJ 146 45 18.8 58 24.3 10 4.2
MFTC 102 31 13.0 43 18.0 5 2.1
LFTC 92 35 14.6 45 18.8 8 3.3
MT 41 38 15.9 55 23.0 6 2.5
cMF 79 29 12.1 51 21.3 6 2.5
LT 24 97 40.6 96 40.2 31 13.0
cLF 80 26 10.9 28 11.7 3 1.3
DESS (n¼ 107) FTJ 226 33 30.8 19 17.8 7 6.5
MFTC 111 34 31.8 28 26.2 7 6.5
LFTC 121 21 19.6 24 22.4 1 0.9
MT 67 28 26.2 25 23.4 6 5.6
cMF 92 29 27.1 26 24.3 6 5.6
LT 74 20 18.7 18 16.8 4 3.7
cLF 116 8 7.5 14 13.1 0 0.0
W. Wirth et al. / Osteoarthritis and Cartilage 19 (2011) 74e83 81consecutive observation periods was observed only in a minority of
the knees. These results indicate that the observed rate of
progression over two consecutive 1-year period may not be highly
stable at an individual level. Further, apparently consistent rates of
change of OV1 in two consecutive years in a cohort were not driven
by identical subregions. Instead, the observed structural progres-
sion of cartilage loss in OA was found to display a strong temporal
and spatial heterogeneity that needs to be taken in account when
investigating the potential impact of disease- or structure modi-
fying drugs or when studying risk factors of OA progression.Authors’ contributions
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